TEAD3 Transcription Factor: From Structural Specificity to Disease Targeting

Published by ANT BIO PTE. LTD.

1. Concept

TEAD3 is a distinctive member of the TEAD transcription factor family, acting as a major nuclear effector of the Hippo-YAP/TAZ pathway. It directs gene expression via a highly conserved TEA DNA-binding domain and a C-terminal YAP/TAZ interaction domain. TEAD3 displays unique structural traits, tissue-specific functions, and context-dependent roles in cancer, reproduction, and neural biology, making it a rising focus for mechanistic research and translational therapy.

2. Research Frontiers

Recent advances have clarified TEAD3’s unique regulatory and functional characteristics:

• TEAD3 uses a cloverleaf-shaped TEA domain with residue Lys52 to selectively bind MCAT DNA elements.
• The TEAD3–YAP complex shows a 5–7° conformational difference from other TEAD paralogs, supporting functional specificity.
• Cys359 palmitoylation serves as a unique, druggable post-translational modification absent in other TEAD proteins.
• TEAD3 exerts dual roles in cancer — oncogenic in gynecologic and breast cancers, tumor-suppressive in colorectal and lung cancers.
• TEAD3 is essential for placental development and linked to pregnancy complications, neural plasticity, and neurodegenerative disease.

3. Research Significance

TEAD3 is functionally irreplaceable across multiple biomedical fields:

• Governs placental development and pregnancy maintenance; its absence causes implantation failure and miscarriage.
• Serves as a context-dependent oncogene or tumor suppressor and a potential prognostic biomarker.
• Participates in neural patterning, synaptic plasticity, and neuropsychiatric disorder risk.
• Represents a highly selective drug target due to its unique palmitoylation site and structural conformation.

Understanding TEAD3 supports innovation in reproductive health, precision oncology, neurodegenerative disease research, and targeted drug development.

4. Molecular Mechanisms and Research Applications

4.1 Structure and DNA-Binding Specificity

TEAD3 contains a conserved ~70-residue TEA domain that specifically recognizes the MCAT motif (5′-CATTCC-3′). Lys52 defines DNA-binding selectivity. The C-terminal region forms a hydrophobic pocket for YAP/TAZ binding. Cryo-EM reveals a unique TEAD3–YAP complex angle that distinguishes its transcriptional output. TEAD3 is modulated by palmitoylation (Cys359), phosphorylation, and SUMOylation, which control stability, localization, and activity.

[Image Location: Diagram of TEAD3–YAP/TAZ–VGLL structural interaction]

4.2 Roles in Placental Development and Pregnancy

TEAD3 is required for trophoblast stem cell maintenance, placental villus formation, and vascular remodeling. Loss causes early embryonic lethality. In preeclampsia and fetal growth restriction, TEAD3 expression is dysregulated. It controls distinct gene programs in cytotrophoblasts and syncytiotrophoblasts, governing proliferation, hormone production, and nutrient transport.

4.3 Dual Function in Cancer Progression

TEAD3 acts as an oncogene in ovarian, endometrial, and ER-positive breast cancers by cooperating with ERα, driving metabolic reprogramming (Warburg effect), and activating proliferation genes. In colorectal cancer and specific lung cancers, it acts as a tumor suppressor by inhibiting β-catenin/TCF and NF-κB signaling. This duality depends on tissue context and cofactor availability.

4.4 Emerging Roles in the Nervous System

TEAD3 is enriched in the embryonic thalamus and hypothalamus and adult hippocampus and amygdala. It supports synaptic plasticity and is associated with schizophrenia, depression, and Alzheimer’s disease. Overexpression may reduce amyloid-β–induced synaptic injury, suggesting neuroprotective potential.

4.5 Targeted Therapeutic Development

TEAD3-targeted strategies include:

• Small molecules targeting the Cys359 palmitoylation pocket.
• Peptides or small molecules disrupting TEAD3–YAP/ERα interactions.
• Gene silencing via siRNA and antisense oligonucleotides (ASOs).

Challenges include off-target reproductive toxicity, high TEAD family homology, and limited biomarkers. Next-generation approaches include allosteric inhibitors, PROTACs, and tissue-specific delivery.

4.6 Research Tools Enabled by ANT BIO PTE. LTD.

High-quality reagents are essential to explore TEAD3 expression, localization, and function:

• Western Blot (WB): Detect endogenous and recombinant TEAD3 protein.
• Immunohistochemistry (IHC-P): Quantify TEAD3 in placental and tumor tissues.
• Immunofluorescence (ICC/IF): Visualize TEAD3 subcellular localization.
• ELISA Kits: Quantify TEAD3 or downstream targets in biological samples.
• Recombinant TEAD3 and YAP proteins: For in vitro binding and inhibitor screening.

5. Our Mission at ANT BIO PTE. LTD.

ANT BIO PTE. LTD. accelerates discovery in developmental biology, oncology, and neuroscience by providing validated, high-performance reagents for TEAD3 and Hippo pathway research. Our portfolio supports basic mechanism study, biomarker detection, drug screening, and translational research with consistent, reliable performance.

6. Featured TEAD3-Related Products

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.